These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


390 related items for PubMed ID: 17689933

  • 1. Bacteraemia in febrile neutropenic cancer patients.
    Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmans M.
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
    [Abstract] [Full Text] [Related]

  • 2. Bloodstream infections in cancer patients with febrile neutropenia.
    Feld R.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S30-3. PubMed ID: 18778919
    [Abstract] [Full Text] [Related]

  • 3. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M, Thamlikitkul V.
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for Gram-negative bacterial infections in febrile neutropenia.
    Cordonnier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G, Bastuji-Garin S, Club de Réflexion sur les Infections en Onco-Hématologie group.
    Haematologica; 2005 Aug; 90(8):1102-9. PubMed ID: 16079110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
    Kern WV, Heiss M, Steinbach G.
    Clin Infect Dis; 2001 Mar 01; 32(5):832-5. PubMed ID: 11229856
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L, Brown M, Sasadeusz J, MacGregor L, Grigg AP.
    J Infect; 2008 Apr 01; 56(4):227-33. PubMed ID: 18342947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M, Cumpston AD, Hobbs GR, Devetten MP, Sarwari AR, Ericson SG.
    Bone Marrow Transplant; 2007 Apr 01; 39(8):477-82. PubMed ID: 17322937
    [Abstract] [Full Text] [Related]

  • 14. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [Abstract] [Full Text] [Related]

  • 15. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, Duarte R, Calvo M, Carratalà J.
    J Antimicrob Chemother; 2011 Mar 15; 66(3):657-63. PubMed ID: 21193475
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications.
    Engel A, Knoll S, Kern P, Kern WV.
    Infection; 2005 Oct 15; 33(5-6):380-2. PubMed ID: 16258872
    [Abstract] [Full Text] [Related]

  • 17. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
    Todeschini G, Tecchio C, Borghero C, D'Emilio A, Pegoraro E, de Lalla F, Benedetti P, Spolaore P, Pellizzer G.
    J Infect; 2006 Oct 15; 53(4):266-73. PubMed ID: 16388852
    [Abstract] [Full Text] [Related]

  • 18. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
    Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N.
    Scand J Infect Dis; 2005 Oct 15; 37(6-7):455-64. PubMed ID: 16012006
    [Abstract] [Full Text] [Related]

  • 19. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
    D'Antonio D, Iacone A, Fioritoni G, Betti S, Dell'Isola M, Quaglietta AM, Accorsi P, Pantalone V, Recchia A, Piergallini A.
    Drugs Exp Clin Res; 1992 Oct 15; 18(4):141-6. PubMed ID: 1451644
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P, Baumgartner JD, Glauser MP, Cometta A.
    Schweiz Med Wochenschr; 2000 Dec 02; 130(48):1837-44. PubMed ID: 11132527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.